Elevation Capital raises Wakefit stake in run-up to IPO; buys Rs 32 crore employees shares
Academy
Empower your mind, elevate your skills
Venture capital firm Elevation Capital , which owns nearly 5% stake in the initial public offering (IPO)-bound mattress and furniture retailer Wakefit , acquired shares worth Rs 32.5 crore this year from the company's current and former employees in the months leading up to the company filing its draft papers.These 203,426 shares, which Elevation Capital bought at Rs 1,600 apiece, were allotted to Wakefit employees under the company's 2019 employee stock option plan (Esop), according to its draft prospectus filed on Friday. Under the Esop 2019 programme, Wakefit had granted a total of 8.4 million stock options, of which 4.5 million vested to date, and 413,271 have been exercised, it said in the prospectus.Wakefit filed its draft red herring prospectus (DRHP) on Friday for the IPO through which it will raise Rs 468 crore in fresh capital. The IPO also comprises an offer-for-sale (OFS) component that will see 58.4 million shares being sold by investors.Notably, Elevation Capital is not participating in the OFS component.Wakefit had facilitated an Esop buyback of Rs 15 crore in 2021 as well, which had benefitted 15-20 employees at the time. Esop buyback programmes typically result in companies facilitating secondary purchases of vested stock options by external investors. In some cases, the companies buy these securities back from their employees.On June 24, software-as-a-service (SaaS) firm Darwinbox bought back Rs 86 crore worth of shares from its employees. Over the last year, several other new-age companies, including IPO-bound at-home services platform Urban Company , society management app Mygate, ecommerce firm Meesho , edtech startups Classplus and Adda247, and managed healthcare provider Even Healthcare , have concluded Esop buybacks.Elevation Capital did not respond to queries sent by ET. Wakefit founder Chaitanya Ramalingegowda said in response to a text message, 'We will be unable to comment on the same.'Wakefit, founded in 2016 by Ankit Garg and Ramalingegowda, initially focussed on sleep products such as mattresses, pillows, and bed frames. Over time, it has expanded its portfolio to include a wide range of home products, including sofas, dining sets, wardrobes, study tables, and bookshelves.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
11 minutes ago
- Time of India
Torrent Pharma revives talks to buy KKR stake in JB Chem
NEW DELHI: Ahmedabad-based Torrent Pharma has revived talks with PE major KKR to buy its stake in Mumbai-based JB Chemicals & Pharmaceuticals in a deal which could cost around Rs 20,000 crore. KKR's nearly 48% stake in JB Chem is valued approximately Rs 13,400 crore at its stock's closing price of Rs 1,803 per share on BSE on Friday. The transaction, which will trigger an open offer by Torrent for up to 26% of the company's stake held by public shareholders, is expected to be finalised soon, sources said. Discussions between KKR and other bidders, including Torrent and Micro Labs, ended last year due to valuation concerns. Efforts to reach Torrent Pharma and JB Chem were futile, and KKR officials were not available for comments. The US private equity major has been seeking to exit its investment in JB Chem for some time, and sources indicated this time the deal with Torrent Pharma is likely to proceed. Typically, private equity firms aim to exit investments within three-to-four years. In March, KKR divested about 7% stake through block deals. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Step-by-Step Warehouse Cleaning Guide SearchMore Learn More Undo In July 2020, the PE major had acquired 54% in JB Chem from the promoters, the Mody family, for approximately Rs 3,100 crore or Rs 745 per share. Post acquisition, the company scaled up its domestic formulations business with a strong growth in cardiac, ophthalmology and anti-parasitic therapies. Over the years, the company ramped up its domestic play and improved its revenue from segments that offer sustainable growth and margins. Using organic and inorganic routes, it launched new products that have helped plug gaps in the business. For 2024-25, JB Pharma recorded a revenue of Rs 3,918 crore, registering 12% growth. With a growth of 12%, it outperformed domestic pharma market, which grew 8%.Its top six brands - Rantac, Cilacar, Cilacar-T, Nicardia, Metrogyl, Azmarda - feature among top 300 domestic brands. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hans India
13 minutes ago
- Hans India
Centre under PM Modi spent Rs 2L cr in 11 yrs on TG farm sector: BJP
Hyderabad: BJP State Spokesperson Rani Rudrama stated that the NDA government at the Centre, led by Prime Minister Narendra Modi, has invested approximately Rs 2 lakh crore into the agriculture sector in Telangana. Addressing the media on Friday, she said that neither the current Congress government in Telangana nor the previous BRS government can develop agriculture with the same clarity and direction demonstrated by the Modi-led government at the national level. From 2014 to 2025, the NDA government has allocated lakhs of crores of rupees to the agriculture sector in Telangana. Notably, Rs 57,556 crore was spent on cotton purchases alone. In 2014, the expenditure on cotton was Rs 3,404 crore, while for the 2023-24 season, Rs 20,998 crore has been budgeted for a single season. During this period, the Centre has invested Rs 57,556 crore in cotton purchases, while the Cotton Corporation of India has bought cotton worth Rs 58,000 crore from farmers in Telangana to date. Rudrama pointed out that when the Congress government came to power, it promised a bonus of Rs 500 per quintal for 14 crops. However, the bonus was only announced for three crops and distributed to only half of the farmers, leaving the rest without any compensation. Even after declaring that the bonus would be provided to only half of the farmers, the process remains incomplete, which she described as a fraud committed by the Congress party.
News18
18 minutes ago
- News18
Sambhv Steel Tubes IPO Gets 30.33x Subscription, Retail Quota Subscribed 8.5x; Check GMP
The GMP of the Sambhv Steel Tubes IPO currently stands at 14.63%, indicating mild listing gains. Sambhv Steel Tubes IPO Day 3: The initial public offering (IPO) of Sambhv Steel Tubes Ltd has been closed today, Friday, June 27, 2025. The issue, which was opened on June 25 to raise Rs 540 crore, has received a strong response amid decent GMP. Here's the subscription status and GMP today. Till 5:00 pm on the final day of bidding on Friday, the IPO received a 30.33 times subscription, garnering bids for 1,40,13,19,920 shares as against the 6,58,69,293 shares on offer. The retail and NII participation stood at 8.56 times and 33.88 times, respectively. Its qualified institutional buyer (QIB) category got a 66.36 times subscription. The Sambhv Steel Tubes IPO received a 0.41x subscription on Day 1 and a 1.27x subscription on Day 2. The IPO consists of a fresh issue of equity shares worth Rs 440 crore and an offer for sale (OFS) of Rs 100 crore by the company's promoter and promoter group shareholders. Sambhv Steel Tubes IPO: Price Band and Lot Size The price band has been fixed at Rs 77 to Rs 82 per equity share of face value Rs 10 each. Investors can bid for a minimum of 182 equity shares and in multiples thereof. A discount of Rs 4 per equity share is being offered to eligible employees bidding in the reserved employee portion. Sambhv Steel Tubes IPO GMP Today According to market observers, the GMP of the IPO currently stands at 14.63%, indicating mild listing gains. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Sambhv Steel Tubes IPO Allotment And Listing Date The IPO allotment will be finalised on Monday, June 30. The equity shares will be listed on both the BSE and the National Stock Exchange (NSE) on July 2. Sambhv Steel IPO: Analysts' Recommendations Most brokerage firms have issued 'Subscribe' recommendations, with most advising investors to take a long-term view due to Sambhv Steel's backward integration, new capacity ramp-up, and strong product portfolio. They added that growth prospects and debt reduction post IPO offer a compelling long-term case. Anand Rathi Research Anand Rathi said Sambhv Steel Tubes benefits from operational efficiency, backward integration, and a strong distribution network, helping it produce value-added products at scale. 'The issue is valuing at P/E of 44 times to its annualized FY25 earnings, EV/EBITDA of 17 times. We believe that the IPO is fully priced and recommend a 'subscribe for long term' rating to the IPO," it said. SBI Securities According to SBI Securities, Sambhv Steel has ramped up its capacity in high-margin stainless steel products, which is likely to boost margins over the next few quarters. 'With ramp up in capacity utilization of CR coils (SS) and Pre-galvanized (GP) pipes expected over the next 2–4 quarters, margins are likely to expand," it said, recommending a 'subscribe' with a long-term horizon. BP Equities BP Equities flagged high valuations, noting that the IPO is priced at a steep 273 times FY25 annualized earnings, but sees merit in the company's future growth plans and debt-reduction strategy. 'It remains well-positioned for future growth, considering that it is the only player in this emerging segment with an intention to repay debt and invest in its subsidiary," the firm said while maintaining a 'subscribe for long term' rating. Canara Bank Securities Canara Bank Securities highlighted Sambhv Steel's integrated model, cost control, and focus on value-added products, stating these factors support a scalable growth path. 'While the valuations appear marginally premium, they are backed by the company's unique integration model, improving product mix, and a strong growth outlook," the brokerage said. Bajaj Broking Recommendation: Subscribe for long-term Bajaj Broking attributed the company's recent lower profitability to provisioning and depreciation costs due to new capacity additions. It expects net profits to rise once debt is reduced post IPO. 'Since the company will clear its debt to the tune of Rs 390 crore post IPO, it will lower its finance cost and translate into higher net profits," it said, assigning a 'subscribe for long term' call. Marwadi Financial Services Marwadi Financial Services views Sambhv Steel as well-positioned to benefit from rising demand for ERW pipes and values it attractively against peers. 'We assign 'subscribe' rating to this IPO as the company is well-positioned to take advantage of the growing demand for quality ERW steel pipes and tubes with its strong process innovation and execution capabilities," the note said. Kunvarji Finserv Kunvarji Finserv cited Sambhv Steel's consistent revenue growth, wide product portfolio, and expanding capacities as reasons for its recommendation. 'We recommend subscribing to this IPO with a medium to long-term view," it said, citing sectoral tailwinds and diversified offerings. Sambhv Steel Tubes IPO Proceeds As per the RHP, Sambhv Steel intends to use the net proceeds from the fresh issue primarily for pre-payment or scheduled repayment of certain outstanding borrowings, and the remaining amount will go towards general corporate purposes. Sambhv Steel Tubes IPO: Breakdown of Offer for Sale The Rs 100-crore OFS component includes shares offloaded by the following stakeholders: Rs 10 crore by Shashank Goyal (Promoter Selling Shareholder) Rs 10 crore by Rohit Goyal (Promoter Selling Shareholder) Rs 35 crore by Kaushlya Goyal (Promoter Group Selling Shareholder) Rs 10 crore by Harsheet Goyal (Promoter Group Selling Shareholder) Rs 35 crore by Rinku Goyal (Other Selling Shareholder) Sambhv Steel IPO: More Details The IPO is being offered through the book-building process in line with SEBI's Issue of Capital and Disclosure Requirements (ICDR) Regulations: Not more than 50% of the net offer will be allocated to qualified institutional buyers (QIBs). Up to 60% of the QIB portion may be allocated to Anchor Investors, with one-third reserved for domestic mutual funds. A minimum of 15% is reserved for Non-Institutional Bidders (NIIs). At least 35% is reserved for retail investors. A portion of the shares is also reserved for eligible employees, who will benefit from the Rs 4 discount. Sambhv Steel Tubes is one of the key manufacturers of electric resistance welded (ERW) steel pipes and structural tubes (hollow section) in India in terms of installed capacity as of March 31, 2024. According to a Crisil report, the demand for domestic steel pipes and tubes is expected to have grown at a compound annual growth rate (CAGR) of 5-6 per cent to 12.50-13.50 million tonnes per annum (MTPA) in FY25 from 8.8 MTPA in FY19. The growth was led by government initiatives to augment urban structural infrastructure and to infuse investments in the oil and gas sector. top videos View all Going forward, domestic steel pipe demand is projected to increase to 18.50-20.50 MTPA in FY29 at 8-9 per cent CAGR between FY25 and FY29 on a high base, the report added. Nuvama Wealth Management Limited and Motilal Oswal Investment Advisors Limited are the Book Running Lead Managers (BRLMs) to the issue. About the Author Mohammad Haris Haris is Deputy News Editor (Business) at He writes on various issues related to markets, economy and companies. Having a decade of experience in financial journalism, Haris has been previously More Stay updated with all the latest business news, including market trends, stock updates, tax, IPO, banking finance, real estate, savings and investments. Get in-depth analysis, expert opinions, and real-time updates—only on News18. Also Download the News18 App to stay updated! tags : initial public offering (IPO) IPO Location : New Delhi, India, India First Published: June 27, 2025, 09:59 IST News business » ipo Sambhv Steel Tubes IPO Gets 30.33x Subscription, Retail Quota Subscribed 8.5x; Check GMP
